로딩 중…
StockDiggingStockDigging

Amylyx Pharmaceuticals, Inc.

AMLX· NASDAQ
$15.67+2.75%
2026-06-18

Price Chart

Amylyx Pharmaceuticals, Inc.+207.25%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$1.74B
Revenue$0.00
Net Income$-150M
Total Assets$294M
Net Assets$273M
Value
P/B6.38x
FCF Yield-6.92%
Profitability
ROE-54.95%
ROA-51.13%
Revenue Growth-100.00%
Financial Health
Debt Ratio7.48%
Total Debt$6M
FCF$-121M
Cash$229M
Current Ratio17.85x
Performance
1Y Return207.25%
1M Return23.00%
From 52W High-15.80%
1Y MDD-30.61%
Trading
Volume723,725 shares
Trading Value$11M
Per Share
EPS$-1.53
BPS$3.23